VTI CEO David W. Vincent, PhD, on the behalf of the World Health Organization (WHO) and ISPE, has recently performed a four (4) day extensive Biological Vaccine Production and Validation workshop for Philippine Food and Drug Administration (P-FDA) in Manila, Philippine. The first of a two part training program. The second part of the training will be an evaluation of the P-FDA inspectors performed during a five (5) day mock inspection of a Biological Vaccine Facility in Asia.
VTI Life Sciences is pleased to announce that it has successfully completed a conversion audit that takes us from the ISO 9001:2008 standard to the ISO 9001:2015 standard. VTI has been ISO 9001 certified for more than 15 years and has successfully completed the conversion audit certifies that VTI is in compliance with the updated ISO 9001 standard.
ISO 9001:2015 is constructed around seven quality management principles: customer focus, leadership, engagement of people, process approach, improvement, evidence base decision making and relationship management.
By achieving the ISO 9001:2015 standard, VTI Life Sciences continues to demonstrate its commitment to quality, industry specifications and customer requirements to ensure that we provide the finest consulting services to our clients in the Life Science industries.
See you at the KENX Validation University Conference in Philadelphia March 25 – 27!
03/27/2019, Wyndham Hotel, Philadelphia, PA